<!-- received="Wed Sep  9 01:27:00 1998 MDT" -->
<!-- sent="Wed, 9 Sep 1998 00:26:54 -0700 (PDT)" -->
<!-- name="Doug Skrecky" -->
<!-- email="oberon@vcn.bc.ca" -->
<!-- subject="conjugated linoleic acid and diabetes" -->
<!-- id="Pine.GSO.3.95.980909002628.1879B-100000@opus.vcn.bc.ca" -->
<!-- inreplyto="" -->
<!-- version=1.10, linesinbody=34 -->
<html><head><title>extropians: conjugated linoleic acid and diabetes</title>
<meta name=author content="Doug Skrecky">
<link rel=author rev=made href="mailto:oberon@vcn.bc.ca" title ="Doug Skrecky">
</head><body>
<h1>conjugated linoleic acid and diabetes</h1>
Doug Skrecky (<i>oberon@vcn.bc.ca</i>)<br>
<i>Wed, 9 Sep 1998 00:26:54 -0700 (PDT)</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#2245">[ date ]</a><a href="index.html#2245">[ thread ]</a><a href="subject.html#2245">[ subject ]</a><a href="author.html#2245">[ author ]</a>
<!-- next="start" -->
<li><a href="2246.html">[ Next ]</a><a href="2244.html">[ Previous ]</a>
<!-- nextthread="start" -->
</ul>
<!-- body="start" -->

<p>
Authors
<br>
  Houseknecht KL.  Vanden Heuvel JP.  Moya-Camarena SY.  Portocarrero CP.  Peck
  LW.  Nickel KP.  Belury MA.
<br>
Institution
<br>
  Department of Animal Sciences, Purdue University, West Lafayette, Indiana
  47907, USA.
<br>
Title
<br>
  Dietary conjugated linoleic
<br>
  acid normalizes impaired glucose tolerance in the Zucker
  diabetic fatty fa/fa rat.
<br>
Source
<br>
  Biochemical &amp; Biophysical Research Communications.  244(3):678-82, 1998 Mar
  27.
<br>
Abstract
<br>
  Conjugated linoleic acid
<br>
  (CLA) is a naturally occurring fatty acid which has
  anti-carcinogenic and anti-atherogenic properties. CLA activates PPAR alpha
  in liver, and shares functional similarities to ligands of PPAR gamma, the
  thiazolidinediones, which are potent insulin sensitizers. We provide the
  first evidence that CLA is able to normalize impaired glucose tolerance and
  improve hyperinsulinemia in the pre-diabetic ZDF rat. Additionally, dietary
  CLA increased steady state levels of aP2 mRNA in adipose tissue of fatty ZDF
  rats compared to controls, consistent with activation of PPAR gamma. The
  insulin sensitizing effects of CLA are due, at least in part, to activation
  of PPAR gamma since increasing levels of CLA induced a dose-dependent
  transactivation of PPAR gamma in CV-1 cells cotransfected with PPAR gamma and
  PPRE X 3-luciferase reporter construct. CLA effects on glucose tolerance and
  glucose homeostasis indicate that dietary CLA may prove to be an important
  therapy for the prevention and treatment of NIDDM.
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="2246.html">[ Next ]</a><a href="2244.html">[ Previous ]</a>
<!-- nextthread="start" -->
</ul>
</body></html>
